Free Trial

QTREX Quantum (QTEX) Competitors

QTREX Quantum logo
$1.14 -0.12 (-9.20%)
As of 03:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

QTEX vs. KRMD, TLSI, FOCL, OWLT, and APYX

Should you buy QTREX Quantum stock or one of its competitors? QTREX Quantum's main competitors and comparable companies include KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), FocalTherics (FOCL), Owlet (OWLT), and Apyx Medical (APYX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does QTREX Quantum compare to KORU Medical Systems?

QTREX Quantum (NASDAQ:QTEX) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

12.7% of QTREX Quantum shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 29.4% of QTREX Quantum shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

QTREX Quantum has a net margin of 0.00% compared to KORU Medical Systems' net margin of -1.78%. QTREX Quantum's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
QTREX QuantumN/A N/A N/A
KORU Medical Systems -1.78%-4.62%-2.90%

KORU Medical Systems has a consensus price target of $6.50, indicating a potential upside of 75.68%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
KORU Medical Systems
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

QTREX Quantum has a beta of 3.97, indicating that its share price is 297% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than QTREX Quantum.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QTREX Quantum$290K154.96-$13.22MN/AN/A
KORU Medical Systems$41.13M3.90-$2.64M-$0.02N/A

In the previous week, KORU Medical Systems had 10 more articles in the media than QTREX Quantum. MarketBeat recorded 13 mentions for KORU Medical Systems and 3 mentions for QTREX Quantum. QTREX Quantum's average media sentiment score of 1.10 beat KORU Medical Systems' score of 0.61 indicating that QTREX Quantum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
KORU Medical Systems
0 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

QTREX Quantum and KORU Medical Systems tied by winning 7 of the 14 factors compared between the two stocks.

How does QTREX Quantum compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and QTREX Quantum (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

TriSalus Life Sciences currently has a consensus price target of $9.20, suggesting a potential upside of 278.60%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe TriSalus Life Sciences is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

QTREX Quantum has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -56.60%.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-56.60% N/A -55.00%
QTREX Quantum N/A N/A N/A

2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 12.7% of QTREX Quantum shares are owned by institutional investors. 16.3% of TriSalus Life Sciences shares are owned by company insiders. Comparatively, 29.4% of QTREX Quantum shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

QTREX Quantum has lower revenue, but higher earnings than TriSalus Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$45.15M3.31-$39.23M-$0.49N/A
QTREX Quantum$290K154.96-$13.22MN/AN/A

In the previous week, TriSalus Life Sciences had 23 more articles in the media than QTREX Quantum. MarketBeat recorded 26 mentions for TriSalus Life Sciences and 3 mentions for QTREX Quantum. QTREX Quantum's average media sentiment score of 1.10 beat TriSalus Life Sciences' score of -0.16 indicating that QTREX Quantum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TriSalus Life Sciences
2 Very Positive mention(s)
6 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TriSalus Life Sciences has a beta of 0.5, meaning that its stock price is 50% less volatile than the broader market. Comparatively, QTREX Quantum has a beta of 3.97, meaning that its stock price is 297% more volatile than the broader market.

Summary

QTREX Quantum beats TriSalus Life Sciences on 8 of the 13 factors compared between the two stocks.

How does QTREX Quantum compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and QTREX Quantum (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

FocalTherics currently has a consensus price target of $9.67, indicating a potential upside of 198.35%. Given FocalTherics' stronger consensus rating and higher possible upside, research analysts plainly believe FocalTherics is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FocalTherics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

FocalTherics has a beta of -0.02, suggesting that its stock price is 102% less volatile than the broader market. Comparatively, QTREX Quantum has a beta of 3.97, suggesting that its stock price is 297% more volatile than the broader market.

QTREX Quantum has a net margin of 0.00% compared to FocalTherics' net margin of -59.77%. QTREX Quantum's return on equity of 0.00% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
FocalTherics-59.77% -223.32% -41.32%
QTREX Quantum N/A N/A N/A

62.7% of FocalTherics shares are held by institutional investors. Comparatively, 12.7% of QTREX Quantum shares are held by institutional investors. 10.1% of FocalTherics shares are held by company insiders. Comparatively, 29.4% of QTREX Quantum shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, FocalTherics had 10 more articles in the media than QTREX Quantum. MarketBeat recorded 13 mentions for FocalTherics and 3 mentions for QTREX Quantum. QTREX Quantum's average media sentiment score of 1.10 beat FocalTherics' score of 0.54 indicating that QTREX Quantum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FocalTherics
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

QTREX Quantum has lower revenue, but higher earnings than FocalTherics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FocalTherics$81.32M1.50-$29.25M-$0.98N/A
QTREX Quantum$290K154.96-$13.22MN/AN/A

Summary

QTREX Quantum beats FocalTherics on 8 of the 15 factors compared between the two stocks.

How does QTREX Quantum compare to Owlet?

Owlet (NYSE:OWLT) and QTREX Quantum (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

QTREX Quantum has a net margin of 0.00% compared to Owlet's net margin of -11.11%. QTREX Quantum's return on equity of 0.00% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-11.11% -57.44% -13.65%
QTREX Quantum N/A N/A N/A

In the previous week, Owlet had 7 more articles in the media than QTREX Quantum. MarketBeat recorded 10 mentions for Owlet and 3 mentions for QTREX Quantum. QTREX Quantum's average media sentiment score of 1.10 beat Owlet's score of 0.60 indicating that QTREX Quantum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

72.6% of Owlet shares are held by institutional investors. Comparatively, 12.7% of QTREX Quantum shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 29.4% of QTREX Quantum shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

QTREX Quantum has lower revenue, but higher earnings than Owlet.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$114.41M0.88-$39.68M-$0.68N/A
QTREX Quantum$290K154.96-$13.22MN/AN/A

Owlet currently has a consensus price target of $15.00, suggesting a potential upside of 337.19%. Given Owlet's stronger consensus rating and higher probable upside, analysts plainly believe Owlet is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Owlet has a beta of 2.17, indicating that its share price is 117% more volatile than the broader market. Comparatively, QTREX Quantum has a beta of 3.97, indicating that its share price is 297% more volatile than the broader market.

Summary

Owlet and QTREX Quantum tied by winning 7 of the 14 factors compared between the two stocks.

How does QTREX Quantum compare to Apyx Medical?

QTREX Quantum (NASDAQ:QTEX) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Apyx Medical has higher revenue and earnings than QTREX Quantum.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QTREX Quantum$290K154.96-$13.22MN/AN/A
Apyx Medical$59.57M1.99-$11.21M-$0.19N/A

12.7% of QTREX Quantum shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 29.4% of QTREX Quantum shares are owned by company insiders. Comparatively, 15.9% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

QTREX Quantum has a net margin of 0.00% compared to Apyx Medical's net margin of -14.16%. QTREX Quantum's return on equity of 0.00% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
QTREX QuantumN/A N/A N/A
Apyx Medical -14.16%-68.79%-13.36%

In the previous week, Apyx Medical had 10 more articles in the media than QTREX Quantum. MarketBeat recorded 13 mentions for Apyx Medical and 3 mentions for QTREX Quantum. QTREX Quantum's average media sentiment score of 1.10 beat Apyx Medical's score of 0.92 indicating that QTREX Quantum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Apyx Medical
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

QTREX Quantum has a beta of 3.97, suggesting that its share price is 297% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market.

Apyx Medical has a consensus price target of $6.20, indicating a potential upside of 120.64%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71

Summary

Apyx Medical beats QTREX Quantum on 8 of the 15 factors compared between the two stocks.

Get QTREX Quantum News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTEX vs. The Competition

MetricQTREX QuantumHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$40.80M$5.98B$7.84B$11.78B
Dividend YieldN/A1.69%2.47%4.41%
P/E RatioN/A39.0934.3430.14
Price / Sales26.264.888.085.36
Price / CashN/A24.1821.0222.32
Price / Book18.924.964.783.86
Net Income-$13.22M$143.12M$3.52B$391.27M
7 Day Performance7.08%-4.65%-4.96%-4.25%
1 Month Performance-24.33%-2.40%-3.18%-5.57%
1 Year PerformanceN/A-0.14%-0.28%-7.49%

QTREX Quantum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTEX
QTREX Quantum
1.6236 of 5 stars
$1.14
-9.2%
N/AN/A$40.80M$1.55MN/A41
KRMD
KORU Medical Systems
3.9396 of 5 stars
$3.89
+23.1%
$6.50
+67.1%
-14.4%$145.15M$41.13MN/A73
TLSI
TriSalus Life Sciences
3.0268 of 5 stars
$2.30
-19.3%
$9.20
+300.0%
-46.7%$141.62M$46.39MN/A102
FOCL
FocalTherics
2.5593 of 5 stars
$3.53
+0.9%
$9.67
+173.8%
N/A$131.35M$81.32MN/A230
OWLT
Owlet
3.3588 of 5 stars
$4.57
+5.4%
$15.00
+227.9%
-67.3%$126.82M$114.41MN/A114

Related Companies and Tools


This page (NASDAQ:QTEX) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners